Old Web
English
Sign In
Acemap
>
authorDetail
>
Eduardo Sanz-Navares
Eduardo Sanz-Navares
Clinical trial
Internal medicine
Adverse effect
Medicine
Placebo
4
Papers
32
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Effectiveness of Diamelandreg; In the Treatment of Diabetic Foot Ulcers: A Randomized and Placebo-Controlled Phase II Clinical Trial
2021
Journal of diabetes & metabolism
Marelys Yanes Quesada
Daysi Navarro Despaigne
Eduardo Cabrera-Rode
Juan J. Lence-Anta
Obdulio Gonzalez-Hern
Ez
Roberto Peña Gener
Eduardo Sanz-Navares
Show All
Source
Cite
Save
Citations (0)
Efficacy of Alzer® and Diamel, Nutritional Supplements, in the Prevention of Severe Diabetic Macular Edema
2020
Open Journal of Ophthalmology
Juana Elvira Maciques Rodríguez
María Emoé Pérez Muñoz
Eduardo Cabrera-Rode
Laura Rosa Redondo Piñó
Raisa Ivis Beltrán Saínz
Teresa Margarita González Calero
Manuel Emiliano Licea Puig
Juan Lence Anta
Rosaralis Paneca Santiesteban
Yordanka Marrero Álvarez
Eduardo Sanz-Navares
Show All
Source
Cite
Save
Citations (0)
Efficacy of Oncoxin-Viusid on the Reduction of Adverse Reactions to Chemotherapy and Radiotherapy in Patients Diagnosed with Cervical Cancer and Endometrial Adenocarcinoma
2020
Journal of Cancer Therapy
Raiza Ruiz Lorente
Daysi Hernández Durán
Jessica García Viamontes
Juan Lence Anta
Rosa Ortiz Reyes
Eduardo Sanz-Navares
Show All
Source
Cite
Save
Citations (1)
Atypical Protein Kinase C{zeta} Suppresses Migration of Mouse Melanoma Cells
2001
Cell Growth & Differentiation
Eduardo Sanz-Navares
Nieves Fernandez
Marcelo G. Kazanietz
Susan A. Rotenberg
Show All
Source
Cite
Save
Citations (31)
1